Andreas Karakatsanis
- Cancer Research top 2%
- Breast Cancer Treatment Studies 44
-
- Breast Lesions and Carcinomas 23
- Oncology top 10%
- Global Cancer Incidence and Screening 10
- HER2/EGFR in Cancer Research 6
- Surgery top 10%
- Breast Implant and Reconstruction 20
-
- Radiomics and Machine Learning in Medical Imaging 5
-
- AI in cancer detection 5
-
- Renal cell carcinoma treatment 4
- Co-authors
- Maria GazouliGeorge PolymeneasDionysios VorosAnna LyberopoulouIoannis PapaconstantinouFredrik WärnbergKosmas DaskalakisPeter Stålberg
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)Cancer Research (2 papers)
- Partner nations
- SwedenUnited KingdomGreece
In The Last Decade
Andreas Karakatsanis
72 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Cancer Research 663
- Pathology and Forensic Medicine 272
- Oncology 383
- Surgery 324
- Neurology 88
Countries citing papers authored by Andreas Karakatsanis
This map shows the geographic impact of Andreas Karakatsanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Karakatsanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Karakatsanis more than expected).
Fields of papers citing papers by Andreas Karakatsanis
This network shows the impact of papers produced by Andreas Karakatsanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Karakatsanis. The network helps show where Andreas Karakatsanis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas Karakatsanis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2024 | 10 | |
| 13 | 2024 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 29 | |
| 16 | 2023 | 3 | |
| 17 | 2020 | 1 | |
| 18 | 2018 | 1 | |
| 19 | The use of superparamagnetic iron oxide (SPIO) as sole method for the detection of sentinel node (SN) in breast cancer. The MONOS study | 2016 | 1 |
| 20 | 2014 | 1 |
About Andreas Karakatsanis
Andreas Karakatsanis is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 79 papers that have together received 1.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (44 papers), Breast Lesions and Carcinomas (23 papers), Breast Implant and Reconstruction (20 papers), Global Cancer Incidence and Screening (10 papers), HER2/EGFR in Cancer Research (6 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), AI in cancer detection (5 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Cancer Research (663 citations), Pathology and Forensic Medicine (272 citations) and Oncology (383 citations). Andreas Karakatsanis has collaborated with scholars based in Sweden, United Kingdom and Greece. Frequent co-authors include Maria Gazouli, George Polymeneas, Dionysios Voros, Anna Lyberopoulou, Ioannis Papaconstantinou, Fredrik Wärnberg, Kosmas Daskalakis, Peter Stålberg, Staffan Eriksson and Per Hellman. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.